Varnavas Constantinou

761 citations

18 papers · 485 indexed · h-index 12

Co-authors: Αchilles Anagnostopoulos Evangelia Yannaki Ioannis Batsis Αthanasios Fassas Evangelia Athanasiou Angeliki Xagorari Eleni Gavriilaki Despina Mallouri
Topics: Hematopoietic Stem Cell Transplantation (10 papers)Acute Lymphoblastic Leukemia research (5 papers)Acute Myeloid Leukemia Research (4 papers)
Cited by: Transplantation Genetics Hematology
Journals: Blood Molecular Therapy Journal of Neurology
Partner nations: Greece United States Sweden

In The Last Decade

Varnavas Constantinou

17 papers receiving 480 citations

Peers

Countries citing papers authored by Varnavas Constantinou

Since Specialization

Citations

This map shows the geographic impact of Varnavas Constantinou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Varnavas Constantinou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Varnavas Constantinou more than expected).

Fields of papers citing papers by Varnavas Constantinou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Varnavas Constantinou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Varnavas Constantinou. The network helps show where Varnavas Constantinou may publish in the future.

Co-authorship network of co-authors of Varnavas Constantinou

This figure shows the co-authorship network connecting the top 25 collaborators of Varnavas Constantinou. A scholar is included among the top collaborators of Varnavas Constantinou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Varnavas Constantinou. Varnavas Constantinou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease 2024 ·Pharmaceuticals ·Eleni Gavriilaki,(unknown),(unknown),Ioannis Batsis,(unknown),(unknown),Despina Mallouri,Varnavas Constantinou,(unknown),(unknown),(unknown),Apostolia Papalexandri,Panayotis Kaloyannidis,(unknown),Zoi Bousiou,Anna Vardi,Evangelia Yannaki,Damianos Sotiropoulos,(unknown)	1
2	Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation 2021 ·Frontiers in Medicine ·Eleni Gavriilaki,Ioanna Sakellari,Thomas Chatzikonstantinou,Despina Mallouri,Ioannis Batsis,(unknown),Stergios Papadimitriou,(unknown),(unknown),Christos Demosthenous,Zoi Bousiou,Varnavas Constantinou,Damianos Sotiropoulos,Αchilles Anagnostopoulos	3
3	Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality 2019 ·Journal of Neurology ·Ioanna Sakellari,Eleni Gavriilaki,Sotirios Papagiannopoulos,Maria Gavriilaki,Ioannis Batsis,Despina Mallouri,Anna Vardi,Varnavas Constantinou,(unknown),Evangelia Yannaki,Christos Smias,(unknown),Dimitrios Kazis,Vasilios Κ. Kimiskidis,Αchilles Anagnostopoulos	13
4	Isolated Extramedullary Relapse as a Poor Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia 2019 ·Biology of Blood and Marrow Transplantation ·Ioanna Sakellari,Eleni Gavriilaki,Ioannis Batsis,Despina Mallouri,Maria Gavriilaki,(unknown),Michalis Iskas,(unknown),Stella Bouziana,Zoi Bousiou,Varnavas Constantinou,(unknown),Damianos Sotiropoulos,Evangelia Yannaki,(unknown),(unknown),(unknown),(unknown),Αchilles Anagnostopoulos	12
5	Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study 2018 ·Annals of Hematology ·Ioanna Sakellari,Eleni Gavriilaki,(unknown),Μαρία Παπαθανασίου,Despina Mallouri,Ioannis Batsis,Zoi Bousiou,Stella Bouziana,Varnavas Constantinou,(unknown),(unknown),Michalis Iskas,(unknown),Anastasia Athanasiadou,Damianos Sotiropoulos,Evangelia Yannaki,(unknown),Αchilles Anagnostopoulos	26
6	Transplant‐associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation 2018 ·Clinical Transplantation ·Eleni Gavriilaki,Ioanna Sakellari,Ioannis Batsis,Despina Mallouri,Zoi Bousiou,Anna Vardi,Evangelia Yannaki,Varnavas Constantinou,Aliki Tsompanakou,(unknown),Panayotis Kaloyannidis,(unknown),Αchilles Anagnostopoulos	50
7	Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single‐center study 2018 ·Journal of Clinical Apheresis ·Ioanna Sakellari,Eleni Gavriilaki,Ioannis Batsis,Despina Mallouri,(unknown),(unknown),Anna Vardi,Varnavas Constantinou,Evangelia Yannaki,Apostolia Papalexandri,Panayotis Kaloyannidis,Christos Smias,Αchilles Anagnostopoulos	30
8	EBV-Related Post-Transplant Lymphoproliferative Disease in Allogeneic Hematopoietic Cell Transplantation: Single-Center Experience and Considerations Regarding CNS Involvement 2018 ·Blood ·Anna Vardi,Ioanna Sakellari,(unknown),Apostolia Papalexandri,Ioannis Batsis,Despina Mallouri,(unknown),Tasoula Touloumenidou,Evangelia Yannaki,Michalis Iskas,Varnavas Constantinou,Eleni Gavriilaki,(unknown),Αchilles Anagnostopoulos	1
9	The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Ioanna Sakellari,Ioannis Batsis,Zoi Bousiou,Despina Mallouri,Varnavas Constantinou,Eleni Gavriilaki,Christos Smias,Evangelia Yannaki,Panayotis Kaloyannidis,(unknown),Niki Stavroyianni,(unknown),Damianos Sotiropoulos,Asimina Fylaktou,Aliki Tsompanakou,(unknown),Αchilles Anagnostopoulos	20
10	Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation 2016 ·Biology of Blood and Marrow Transplantation ·Ioanna Sakellari,Despina Mallouri,Eleni Gavriilaki,Ioannis Batsis,(unknown),Varnavas Constantinou,Apostolia Papalexandri,(unknown),(unknown),Anastasia Athanasiadou,Evangelia Yannaki,Damianos Sotiropoulos,Christos Smias,Αchilles Anagnostopoulos	24
11	Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with β‐thalassemia major 2016 ·Transfusion ·Varnavas Constantinou,(unknown),(unknown),(unknown),(unknown),George Stamatoyannopoulos,Αchilles Anagnostopoulos,Evangelia Yannaki	11
12	Survival Advantage with Comparable Complete Chimerism Patterns in Reduced Toxicity Treosulfan-Based Vs Reduced Intensity Busulfan-Based Conditinioning Regimen in AML/MDS Patients Undergoing Allogeneic Haematopoietic Cell Transplantation 2015 ·Blood ·Ioannis Batsis,Ioanna Sakellari,Apostolia Papalexandri,Despina Mallouri,(unknown),(unknown),(unknown),Eleni Gavriilaki,Varnavas Constantinou,Evangelia Yannaki,Panayotis Kaloyannidis,(unknown),Damianos Sotiropoulos,(unknown),Christos Smias,Αchilles Anagnostopoulos	0
13	Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbb ^th-3 Mouse Model 2014 ·Human Gene Therapy Methods ·Nikoletta Psatha,(unknown),(unknown),(unknown),(unknown),Varnavas Constantinou,Evangelia Athanasiou,Minas Arsenakis,Αchilles Anagnostopoulos,Thalia Papayannopoulou,George Stamatoyannopoulos,Evangelia Yannaki	16
14	Hematopoietic Stem Cell Mobilization for Gene Therapy: Superior Mobilization by the Combination of Granulocyte–Colony Stimulating Factor Plus Plerixafor in Patients with β-Thalassemia Major 2013 ·Human Gene Therapy ·Evangelia Yannaki,(unknown),(unknown),Varnavas Constantinou,(unknown),(unknown),(unknown),Erica C. Jonlin,Thalia Papayannopoulou,Αchilles Anagnostopoulos,George Stamatoyannopoulos	46
15	Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects 2011 ·Molecular Therapy ·Evangelia Yannaki,Thalia Papayannopoulou,Erica C. Jonlin,(unknown),(unknown),Angeliki Xagorari,Pamela S. Becker,Nikoletta Psatha,Ioannis Batsis,Panayotis Kaloyannidis,(unknown),Varnavas Constantinou,(unknown),Konstantia Kotta,Aglaia Athanassiadou,Αchilles Anagnostopoulos,Αthanasios Fassas,George Stamatoyannopoulos	52
16	Hematopoietic Cell Mobilization for Gene Therapy of Adult Patients with Severe Beta-Thalassemia: The Challenge of Splenectomy and the Role of Plerixafor 2011 ·Blood ·Evangelia Yannaki,Thalia Papayannopoulou,Erica C. Jonlin,(unknown),(unknown),Angeliki Xagorari,Pamela S. Becker,Nikoletta Psatha,Ioannis Batsis,Panayotis Kaloyannidis,(unknown),Varnavas Constantinou,(unknown),Konstantia Kotta,Aglaia Athanassiadou,Αchilles Anagnostopoulos,Αthanasios Fassas,George Stamatoyannopoulos	1
17	Mobilization of Hematopoietic Stem Cells in a Thalassemic Mouse Model: Implications for Human Gene Therapy of Thalassemia 2009 ·Human Gene Therapy ·Evangelia Yannaki,Nikoletta Psatha,Evangelia Athanasiou,(unknown),Varnavas Constantinou,Αναστασία Παπαδοπούλου,(unknown),Panayotis Kaloyannidis,Ioannis Batsis,Minas Arsenakis,Αchilles Anagnostopoulos,Αthanasios Fassas	15
18	G-CSF–primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs 2005 ·Experimental Hematology ·Evangelia Yannaki,Evangelia Athanasiou,Angeliki Xagorari,Varnavas Constantinou,Ioannis Batsis,(unknown),(unknown),Αchilles Anagnostopoulos,Αthanasios Fassas	164

About Varnavas Constantinou

Varnavas Constantinou is a scholar working on Hematology, Genetics and Transplantation, having authored 18 papers that have together received 485 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Lymphoblastic Leukemia research (5 papers) and Acute Myeloid Leukemia Research (4 papers). The work is most often cited by research in Transplantation (45 citations), Genetics (147 citations) and Hematology (154 citations). Varnavas Constantinou has collaborated with scholars based in Greece, United States and Sweden. Frequent co-authors include Αchilles Anagnostopoulos, Evangelia Yannaki, Ioannis Batsis, Αthanasios Fassas, Evangelia Athanasiou, Angeliki Xagorari, Eleni Gavriilaki, Despina Mallouri, Panayotis Kaloyannidis and Ioanna Sakellari. Their work appears in journals such as Blood, Molecular Therapy and Journal of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact